# Nitrofurantoin Monohydrate/ Macrocrystalline

NDC: 0904-7137
Generic name: Nitrofurantoin Monohydrate/Macrocrystalline
Labeler / Manufacturer: Major Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20110525
Marketing ended: 20260531
FDA application: NDA020064

## Active ingredients

- NITROFURANTOIN: 25 mg/1
- NITROFURANTOIN MONOHYDRATE: 75 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0904-7137"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0904-7137
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b2c95493-7bd7-414c-8ea8-61d55c5cedca